These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29300205)

  • 1. Effect of Pharmacist-Led Interventions on (Non)Motor Symptoms, Medication-Related Problems, and Quality of Life in Parkinson Disease Patients: A Pilot Study.
    Stuijt C; Karapinar-Çarkit F; van den Bemt B; van Laar T
    Clin Neuropharmacol; 2018; 41(1):14-19. PubMed ID: 29300205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
    Chaudhuri KR; Hand A; Obam F; Belsey J
    J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence therapy improves medication adherence and quality of life in people with Parkinson's disease: a randomised controlled trial.
    Daley DJ; Deane KH; Gray RJ; Clark AB; Pfeil M; Sabanathan K; Worth PF; Myint PK
    Int J Clin Pract; 2014 Aug; 68(8):963-71. PubMed ID: 24750544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).
    Fleisher JE; Dahodwala NA; Xie SX; Mayo M; Weintraub D; Chodosh J; Shea JA
    J Parkinsons Dis; 2016 Apr; 6(2):383-92. PubMed ID: 27061070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care.
    Hedegaard U; Hallas J; Ravn-Nielsen LV; Kjeldsen LJ
    Res Social Adm Pharm; 2016; 12(2):302-18. PubMed ID: 26088274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of a Structured Medication Review on Quality of Life in Parkinson's Disease.
    Oonk NGM; Movig KLL; van der Palen J; Nibourg SAF; Koehorst-Ter Huurne K; Nijmeijer HW; van Kesteren ME; Dorresteijn LDA
    J Parkinsons Dis; 2022; 12(4):1295-1306. PubMed ID: 35253776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease.
    Craig LH; Svircev A; Haber M; Juncos JL
    Mov Disord; 2006 Dec; 21(12):2127-33. PubMed ID: 17044088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study.
    Herman T; Giladi N; Gruendlinger L; Hausdorff JM
    Arch Phys Med Rehabil; 2007 Sep; 88(9):1154-8. PubMed ID: 17826461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'PD Warrior' exercise programme improves motor outcomes and quality of life in patients with early Parkinson disease: results of a pilot study.
    Tucak C; Chih H; Mastaglia F; Rodrigues J
    Intern Med J; 2024 May; 54(5):823-832. PubMed ID: 38100122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of 2 different water-based exercise training programs in patients with Parkinson's disease: a pilot study.
    Ayán C; Cancela J
    Arch Phys Med Rehabil; 2012 Oct; 93(10):1709-14. PubMed ID: 22497803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring pain perceptions and medication taking behavior at the end of life: a pilot study.
    Hutt E; Fink RM; Nelson-Marten P; Jones J; Kutner JS
    Am J Hosp Palliat Care; 2014 Nov; 31(7):726-9. PubMed ID: 24065272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
    Kalista T; Lemay V; Cohen L
    J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of the quality of life in Parkinson's disease: results of a cohort study from Southwest China.
    Wu Y; Guo XY; Wei QQ; Song W; Chen K; Cao B; Ou RW; Zhao B; Shang HF
    J Neurol Sci; 2014 May; 340(1-2):144-9. PubMed ID: 24679837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist Competences and Impact of Pharmacist Intervention on Medication Adherence: an Observational Study.
    Boskovic J; Mestrovic A; Leppée M; Bago M; Sostar Z; Naletilic D
    Psychiatr Danub; 2016 Dec; 28(4):420-427. PubMed ID: 27855435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol: Effectiveness of patient centered pharmacist care in improving medication adherence, clinical parameters and quality of life among hemodialysis patients.
    Paneerselvam GS; Aftab RA; Sirisinghe RG; Lai PSM; Lim SK
    PLoS One; 2022; 17(2):e0263412. PubMed ID: 35180236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
    Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
    J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient Enhanced Multidisciplinary Care Effects on the Quality of Life for Parkinson Disease: A Quasi-Randomized Controlled Trial.
    Marumoto K; Yokoyama K; Inoue T; Yamamoto H; Kawami Y; Nakatani A; Fukazawa Y; Hosoe Y; Yamasaki A; Domen K
    J Geriatr Psychiatry Neurol; 2019 Jul; 32(4):186-194. PubMed ID: 30966869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dancing for Parkinson Disease: A Randomized Trial of Irish Set Dancing Compared With Usual Care.
    Shanahan J; Morris ME; Bhriain ON; Volpe D; Lynch T; Clifford AM
    Arch Phys Med Rehabil; 2017 Sep; 98(9):1744-1751. PubMed ID: 28336345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.